Flavone Derivative Enhancing Antitumor Activity and Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antitumor drugs, such as traditional chemotherapeutic agents and flavonoids like Icaritin, face challenges including low specificity, high toxicity, and multidrug resistance, as well as poor solubility and bioavailability, limiting their clinical effectiveness.
Innovation Solution
A novel flavone derivative with modified structure, represented by structural formula I, is developed to enhance antitumor activity and solubility, incorporating specific substituents and residues, and formulated into various crystal forms, hydrates, or solvates for improved pharmaceutical compositions, health foods, and foods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional chemotherapeutic drugs are used, then therapeutic effects are achieved, but toxicity and side effects increase
Solution Approach 1:
The patent modifies the chemical structure of flavonoids by changing molecular parameters (adding specific substituents at defined positions) to improve therapeutic index. The structural modifications include adding amino acid residues, sugar residues, and other functional groups that enhance tumor selectivity while reducing off-target toxicity.
Solution Approach 2:
The patent creates composite molecular structures by combining flavone core with various functional groups and residues. The compounds incorporate multiple functional moieties (e.g., isopentenyl groups, amino acid侧链, sugar units) that work synergistically to achieve both antitumor activity and reduced toxicity.
2Reliability
If Icaritin is used, then antitumor activity is achieved, but solubility and bioavailability decrease
Solution Approach 1:
The patent systematically modifies the physical-chemical parameters of Icaritin by introducing hydrophilic groups (carboxyl, hydroxyl, amino groups) and conjugating with sugar residues. These changes alter the molecular polarity and interaction with biological membranes, significantly improving aqueous solubility and cellular uptake.
Solution Approach 2:
The patent uses sugar residues and amino acid moieties as intermediary structures that bridge the hydrophobic flavone core and the aqueous cellular environment. These intermediary groups facilitate transport across cell membranes and enhance bioavailability without compromising the core antitumor activity.
3Object-affected harmful factors
If flavonoids are used, then safety is improved, but antitumor activity is insufficient
Solution Approach 1:
The patent applies local quality modification by introducing functional groups at specific positions on the flavone ring system (positions 3, 5, 7, 8, 6'). Each position is selectively substituted with groups having specific biological activities, creating local areas of enhanced pharmacological function while maintaining overall safety profile.
Solution Approach 2:
The patent creates multi-functional flavone derivatives where a single molecular structure incorporates multiple biological activities: antitumor proliferation inhibition, apoptosis induction, and reduced toxicity. The compounds simultaneously target multiple pathways (cell cycle regulation, DNA damage response, anti-apoptosis) to achieve enhanced antitumor efficacy.
Data Source
AI summary
Provided are a flavone derivative represented by formula I and a pharmaceutically acceptable salt, hydrate or solvate thereof. (I) In formula I, R1 is selected from the group consisting of H, C1-4 alkyl, amino and C1-4 acyl; R2 is isopentenyl or 2-hydroxy-isopentyl; R3 is selected from the group consisting of H, methyl and deuterated methyl; R4 is selected from the group consisting of C1-4 alkyl, amino, C1-4 acyl, and (II), wherein R5 represents a monosaccharide residue or an oligosaccharide residue; L is selected from the group consisting of a polypeptide, C1-C20 linear alkyl or a derivative thereof, a derivative of C1-C20 linear or branched acyl, C1-C20 glycol or a derivative thereof, and (III), wherein Y is (IV), a is an integer from 0-100, b is an integer from 1-100, c is an integer from 1-10, d is an integer from 0-100, and e is an integer from 0-100. The flavone derivative according to the present invention exhibits an potent and broad-spectrum anti-cancer activity.